Interpretation of c-reactive protein concentrations in critically Ill patients

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Lelubre, Christophe ^a   Anselin, Sophie ^a   Zouaoui Boudjeltia, Karim ^b   Biston, Patrick ^a   Piagnerelli, Michaël ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Centre Hospitalier Universitaire de Charleroi   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; PADGEM PROTEIN; SERUM AMYLOID P; BIOLOGICAL MARKER;

ACUTE PHASE RESPONSE; ANTIINFLAMMATORY ACTIVITY; APACHE; BACTERIAL LOAD; BINDING SITE; CHILD PUGH SCORE; COMMUNITY ACQUIRED PNEUMONIA; CRITICALLY ILL PATIENT; FIBRINOLYSIS; GLYCOSYLATION; HUMAN; INFLAMMATION; INTENSIVE CARE; LEUKOCYTE ACTIVATION; LIGAND BINDING; LIVER FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PRECIPITATION; RADIOIMMUNOASSAY; REVIEW; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; STREPTOCOCCUS PNEUMONIA; VENTILATOR ASSOCIATED PNEUMONIA; BIOSYNTHESIS; CRITICAL ILLNESS; INTENSIVE CARE UNIT; METABOLISM; PATHOLOGY;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CRITICAL ILLNESS; HUMANS; INTENSIVE CARE UNITS; LIVER FAILURE; SEPSIS;

EID: 84888628521     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/124021     Document Type: Review

References (73)

1. Angus D. C., Linde-Zwirble W. T., Lidicker J., Clermont G., Carcillo J., Pinsky M. R., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 2001 29 7 1303 1310 2-s2.0-0034958947 (Pubitemid 32641789)
2. Kumar G., Kumar N., Taneja A., Kaleekal T., Tarima S., McGinley E., Jimenez E., Mohan A., Khan R. A., Whittle J., Jacobs E., Nanchal R., Nationwide trends of severe sepsis in the 21st century (2000-2007). Chest 2011 140 5 1223 1231 2-s2.0-81055145174 10.1378/chest.11-0352
3. Vincent J. L., Sakr Y., Sprung C. L., Ranieri V. M., Reinhart K., Gerlach H., Moreno R., Carlet J., Le Gall J., Payen D., Sepsis in European intensive care units: results of the SOAP study. Critical Care Medicine 2006 34 2 344 353 2-s2.0-31344461826 10.1097/01.CCM.0000194725.48928.3A (Pubitemid 43145611)
4. Vincent J. L., Rello J., Marshall J., Silva E., Anzueto A., Martin C. D., Moreno R., Lipman J., Gomersall C., Sakr Y., Reinhart K., International study of the prevalence and outcomes of infection in intensive care units. Journal of the American Medical Association 2009 302 21 2323 2329 2-s2.0-72249087115 10.1001/jama.2009.1754
5. Vincent J. L., Abraham E., Annane D., Bernard G., Rivers E., Van den Berghe G., Reducing mortality in sepsis: new directions. Critical Care 2002 6 supplement 3 S1 S18 2-s2.0-0036972302 10.1186/cc1860 (Pubitemid 36432661)
6. Emerging Risk factors collaboration, Kaptoge S., Di Angelantonio E., C-reactive protein, fibrinogen, and cardiovascular disease prediction. The New England Journal of Medicine 2012 367 14 1310 1320 10.1056/NEJMoa1107477
7. Pepys M. B., Hirschfield G. M., C-reactive protein: a critical update. Journal of Clinical Investigation 2003 111 12 1805 1812 2-s2.0-0042744797 10.1172/JCI200318921 (Pubitemid 38057722)
8. Molins B., Peña E., Vilahur G., Mendieta C., Slevin M., Badimon L., C-reactive protein isoforms differ in their effects on thrombus growth. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 12 2239 2246 2-s2.0-57549119306 10.1161/ATVBAHA.108.174359
9. Tillet W. S., Francis T., Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. Journal of Experimental Medicine 1930 52 4 561 571 10.1084/jem.52.4.561
10. Shine B., de Beer F. C., Pepys M. B., Solid phase radioimmunoassays for human C-reactive protein. Clinica Chimica Acta 1981 117 1 13 23 2-s2.0-0019840538 10.1016/0009-8981(81)90005-X (Pubitemid 12228482)
11. Lakoski S. G., Cushman M., Criqui M., Rundek T., Blumenthal R. S., D'Agostino R. B. Jr., Herrington D. M., Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. American Heart Journal 2006 152 3 593 598 2-s2.0-33747193034 10.1016/j.ahj.2006.02.015 (Pubitemid 44233418)
12. Pfäfflin A., Schleicher E., Inflammation markers in point-of-care testing (POCT). Analytical and Bioanalytical Chemistry 2009 393 5 1473 1480 2-s2.0-60749126275 10.1007/s00216-008-2561-3
13. Vigushin D. M., Pepys M. B., Hawkins P. N., Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. Journal of Clinical Investigation 1993 91 4 1351 1357 2-s2.0-0027316064 (Pubitemid 23127332)
14. Juma W. M., Lira A., Marzuk A., Marzuk Z., Hakim A. M., Thompson C. S., C-reactive protein expression in a rodent model of chronic cerebral hypoperfusion. Brain Research 2011 1414 85 93 2-s2.0-80052955944 10.1016/j.brainres.2011.07.047
15. Meuwissen M., van der Wal A. C., Niessen H. W. M., Koch K. T., De Winter R. J., Van Der Loos C. M., Rittersma S. Z. H., Chamuleau S. A. J., Tijssen J. G. P., Becker A. E., Piek J. J., Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction. Journal of Clinical Pathology 2006 59 2 196 201 2-s2.0-32544448716 10.1136/jcp.2005.027235 (Pubitemid 43235587)
16. Kuta A. E., Baum L. L., C-reactive protein is produced by a small number of normal human peripheral blood lymphocytes. Journal of Experimental Medicine 1986 164 1 321 326 2-s2.0-0022536320 (Pubitemid 16069243)
17. Calabro P., Chang D. W., Willerson J. T., Yeh E. T. H., Release of C-reactive protein in response to inflammatory cytokines by human adipocytes: linking obesity to vascular inflammation. Journal of the American College of Cardiology 2005 46 6 1112 1113 2-s2.0-24944454234 10.1016/j.jacc.2005.06.017 (Pubitemid 41316523)
18. Ugarte H., Silva E., Mercan D., de Mendonca A., Vincent J., Procalcitonin used as a marker of infection in the intensive care unit. Critical Care Medicine 1999 27 3 498 504 2-s2.0-0000769626 (Pubitemid 29162669)
19. Reny J. L., Vuagnat A., Ract C., Benoit M. O., Safar M., Fagon J., Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Critical Care Medicine 2002 30 3 529 535 2-s2.0-0036191395 (Pubitemid 34214612)
20. Póvoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., Sabino H., C-reactive protein as a marker of infection in critically ill patients. Clinical Microbiology and Infection 2005 11 2 101 108 2-s2.0-13844266391 10.1111/j.1469-0691.2004.01044.x (Pubitemid 40253814)
21. Póvoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., Sabino H., Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Critical Care 2006 10 2 R63 2-s2.0-34248562162 10.1186/cc4892 (Pubitemid 47079868)
22. Lobo S. M., Lobo F. R., Bota D. P., Lopes-Ferreira F., Soliman H. M., Mélot C., Vincent J., C-reactive protein levels correlate with mortality and organ failure in critically III patients. Chest 2003 123 6 2043 2049 2-s2.0-0037709770 10.1378/chest.123.6.2043 (Pubitemid 36706731)
23. Castelli G. P., Pognani C., Cita M., Stuani A., Sgarbi L., Paladini R., Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiologica 2006 72 1-2 69 80 2-s2.0-32544437520 (Pubitemid 43230810)
24. Silvestre J., Póvoa P., Coelho L., Almeida E., Moreira P., Fernandes A., Mealha R., Sabino H., Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Medicine 2009 35 5 909 913 2-s2.0-65549143743 10.1007/s00134-009-1402-y
25. Póvoa P., Teixeira-Pinto A. M., Carneiro A. H., C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Critical Care 2011 15 4 R169 2-s2.0-79960559696 10.1186/cc10313
26. Vandijck D. M., Hoste E. A., Blot S. I., Depuydt P. O., Peleman R. A., Decruyenaere J. M., Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study. BMC Infectious Diseases 2007 7 106 2-s2.0-35548984365 10.1186/1471-2334-7-106 (Pubitemid 350001973)
27. Póvoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., Sabino H., Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection. Clinical Infectious Diseases 2005 40 12 1855 1857 2-s2.0-20444412717 10.1086/430382 (Pubitemid 40799959)
28. Zhang Z., Ni H., C-reactive protein as a predictor of mortality in critically ill patients: a meta-analysis and systematic review. Anaesthesia and Intensive Care 2011 39 5 854 861 2-s2.0-80053025890
29. Póvoa P., Souza-Dantas V. C., Soares M., Salluh J. I. F., C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia. Critical Care 2011 15 3 R129 2-s2.0-79955984559 10.1186/cc10242
30. Fraunberger P., Wang Y., Holler E., Parhofer K. G., Nagel D., Walli A. K., Seidel D., Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 2006 26 1 10 12 2-s2.0-33747169897 10.1097/01.shk.0000215319.06866.bd (Pubitemid 44296999)
31. Su L., Han B., Liu C., Value of soluble TREM-1, procalcitonin and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infectious Diseases 2012 12 157 10.1186/1471-2334-12-157
32. Christ-Crain M., Jaccard-Stolz D., Bingisser R., Gencay M. M., Huber P. R., Tamm M., Müller B., Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. The Lancet 2004 363 9409 600 607 2-s2.0-1342265610 10.1016/S0140-6736(04)15591-8 (Pubitemid 38264177)
33. Peres Bota D., Van Nuffelen M., Zakariah A. N., Vincent J., Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. Journal of Laboratory and Clinical Medicine 2005 146 6 347 351 2-s2.0-28244469653 10.1016/j.lab.2005.08.005 (Pubitemid 41712021)
34. Silvestre J. P., Coehlo L. M., Povoa P. M., Impact of fulminant hepatic failure in C-reactive protein? Journal of Critical Care 2010 25 4 657.e7 657.12 10.1016/j.jcrc.2010.02.004
35. Hillas G., Vassilakopoulos T., Plantza P., Rasidakis A., Bakakos P., C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia. European Respiratory Journal 2010 35 4 805 811 2-s2.0-77951166665 10.1183/09031936.00051309
36. Seligman R., Meisner M., Lisboa T. C., Hertz F. T., Filippin T. B., Fachel J. M. G., Teixeira P. J. Z., Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Critical Care 2006 10 5 R125 2-s2.0-33847755676 10.1186/cc5036 (Pubitemid 47079171)
37. Póvoa P., Coelho L., Almeida E., Fernandes A., Mealha R., Moreira P., Sabino H., C-reactive protein as a marker of ventilator-associated penumonia resolution: a pilot study. European Respiratory Journal 2005 25 5 804 812 2-s2.0-18744367590 10.1183/09031936.05.00071704 (Pubitemid 40667677)
38. Coelho L., Póvoa P., Almeida E., Fernandes A., Mealha R., Moreira P., Sabino H., Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Critical Care 2007 11 R92 2-s2.0-34648828385 10.1186/cc6105 (Pubitemid 47457079)
39. Coelho L. M., Salluh J. I., Soares M., Bozza F., Verdeal J. C. J., Castro-Faria-Neto H. C., Lapa e Silva J. R., Bozza P. T., Povoa P., Patterns of C-reactive protein ratio response in severe community-acquired pneumonia: a cohort study. Critical Care 2012 16 R53 2-s2.0-84858738850 10.1186/cc11291
40. Bajwa E. K., Khan U. A., Januzzi J. L., Gong M. N., Thompson B. T., Christiani D. C., Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest 2009 136 2 471 480 2-s2.0-68849093117 10.1378/chest.08-2413
41. Lisboa T. C., Seligman R., Diaz E., Rodriguez A., Teixeira P. J. Z., Rello J., C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Critical Care Medicine 2008 36 1 166 171 2-s2.0-37549027197 10.1097/01.CCM.0000297886.32564.CF
42. Bruns A. H. W., Oosterheert J. J., Hak E., Hoepelman A. I. M., Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. European Respiratory Journal 2008 32 3 726 732 2-s2.0-56549127312 10.1183/09031936.00003608
43. Menendez R., Sahuquillo-Arce J. M., Reyes S., Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia. Chest 2012 141 6 1537 1545 10.1378/chest.11-1446
44. Rowe I. F., Soutar A. K., Trayner I. M., Rabbit and rat C-reactive proteins bind apolipoprotein B-containing lipoproteins. Journal of Experimental Medicine 1984 159 2 604 616 2-s2.0-0021346651 (Pubitemid 14193998)
45. Gershov D., Kim S., Brot N., Elkon K. B., C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity. Journal of Experimental Medicine 2000 192 9 1353 1363 2-s2.0-0034613686 10.1084/jem.192.9.1353
46. Thomas-Rudolph D., Du Clos T. W., Snapper C. M., Mold C., C-reactive protein enhances immunity to Streptococcus pneumoniae by targeting uptake to Fc γ R on dendritic cells. Journal of Immunology 2007 178 11 7283 7291 2-s2.0-34249809121 (Pubitemid 46847455)
47. Agrawal A., Shrive A. K., Greenhough T. J., Volanakis J. E., Topology and structure of the C1q-binding site on C-reactive protein. Journal of Immunology 2001 166 6 3998 4004 2-s2.0-0035869290 (Pubitemid 32224928)
48. Okemefuna A. I., Nan R., Miller A., Gor J., Perkins S. J., Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations. Journal of Biological Chemistry 2010 285 2 1053 1065 2-s2.0-74049141427 10.1074/jbc.M109.044529
49. Hellwage J., Jokiranta T. S., Friese M. A., Wolk T. U., Kampen E., Zipfel P. F., Meri S., Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. Journal of Immunology 2002 169 12 6935 6944 2-s2.0-0037114145 (Pubitemid 36899280)
50. Xia D., Samols D., Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proceedings of the National Academy of Sciences of the United States of America 1997 94 6 2575 2580 2-s2.0-0030909608 10.1073/pnas.94.6.2575 (Pubitemid 27136917)
51. Eisenhardt S. U., Thiele J. R., Bannasch H., Stark G. B., Peter K., C-reactive protein: how conformational changes influence inflammatory properties. Cell Cycle 2009 8 23 3885 3892 2-s2.0-74849097894
52. Wang Q., Zhu X., Xu Q., Ding X., Chen Y. E., Song Q., Effect of C-reactive protein on gene expression in vascular endothelial cells. American Journal of Physiology 2005 288 4 H1539 H1545 2-s2.0-15744369475 10.1152/ajpheart.00963.2004 (Pubitemid 40417973)
53. Hirschfield G. M., Herbert J., Kahan M. C., Pepys M. B., Human C-reactive protein does not protect against acute lipopolysaccharide challenge in mice. Journal of Immunology 2003 171 11 6046 6051 2-s2.0-0344153861 (Pubitemid 37467224)
54. Cirillo P., Golino P., Calabrò P., Calì G., Ragni M., De Rosa S., Cimmino G., Pacileo M., De Palma R., Forte L., Gargiulo A., Corigliano F. G., Angri V., Spagnuolo R., Nitsch L., Chiariello M., C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovascular Research 2005 68 1 47 55 2-s2.0-24344490417 10.1016/j.cardiores.2005.05.010 (Pubitemid 41253555)
55. Devaraj S., Xu D. Y., Jialal I., C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 2003 107 3 398 404 2-s2.0-0037469261
56. Fourrier F., Severe sepsis, coagulation and fibrinolysis: dead end or one way? Critical Care Medicine 2012 40 9 2704 2708 10.1097/CCM.0b013e318258ff30
57. Bisoendial R. J., Kastelein J. J. P., Levels J. H. M., Zwaginga J. J., Van Den Bogaard B., Reitsma P. H., Meijers J. C. M., Hartman D., Levi M., Stroes E. S. G., Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circulation Research 2005 96 7 714 716 2-s2.0-20244363246 10.1161/01.RES.0000163015.67711.AB (Pubitemid 40559509)
58. Bisoendial R. J., Kastelein J. J. P., Peters S. L. M., Levels J. H. M., Birjmohun R., Rotmans J. I., Hartman D., Meijers J. C. M., Levi M., Stroes E. S. G., Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects. Journal of Lipid Research 2007 48 4 952 960 2-s2.0-34147182630 10.1194/jlr.P600014-JLR200 (Pubitemid 46557900)
59. Pepys M. B., Hawkins P. N., Kahan M. C., Tennent G. A., Gallimore J. R., Graham D., Sabin C. A., Zychlinsky A., De Diego J., Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself. Circulation Research 2005 97 11 e97 e103 2-s2.0-33644674993 10.1161/01.RES.0000193595.03608.08
60. Boudjeltia K. Z., Piagnerelli M., Brohée D., Guillaume M., Cauchie P., Vincent J., Remacle C., Bouckaert Y., Vanhaeverbeek M., Relationship between CRP and hypofibrinolysis: is this a possible mechanism to explain the association between CRP and outcome in critically ill patients? Thrombosis Journal 2004 2 7 2-s2.0-23944517423 10.1186/1477-9560-2-7 (Pubitemid 41630793)
61. Grad E., Golomb M., Mor-Yosef I., Koroukhov N., Lotan C., Edelman E. R., Danenberg H. D., Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury. American Journal of Physiology 2007 293 1 H489 H495 2-s2.0-34249744707 10.1152/ajpheart.01418.2006 (Pubitemid 47105107)
62. Clapp B. R., Hirschfield G. M., Storry C., Gallimore J. R., Stidwill R. P., Singer M., Deanfield J. E., MacAllister R. J., Pepys M. B., Vallance P., Hineorani A. D., Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 2005 111 12 1530 1536 2-s2.0-20144388326 10.1161/01.CIR.0000159336.31613.31 (Pubitemid 40470649)
63. Chen J., Jin J., Song M., Dong H., Zhao G., Huang L., C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products. Gene 2012 496 2 128 135 2-s2.0-84857189739 10.1016/j.gene.2011.12.039
64. Fujii H., Li S. H., Szmitko P. E., Fedak P. W. M., Verma S., C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 11 2476 2482 2-s2.0-33750205432 10.1161/01.ATV.0000242794.65541.02 (Pubitemid 44607468)
65. Kumar A., Optimizing antimicrobial therapy in sepsis and septic shock. Critical Care Clinics 2009 25 4 733 751 2-s2.0-70350594710 10.1016/j.ccc.2009. 08.004
66. Pierrakos C., Vincent J., Sepsis biomarkers: a review. Critical Care 2010 14 1 R15 2-s2.0-77956628404 10.1186/cc8872
67. Salluh J. I. F., Rabello L. S. C. F., Rosolem M. M., Soares M., Bozza F. A., Verdeal J. C. R., Mello G. W., Castro Faria Neto H. C., Lapa e Silva J. R., Bozza P. T., The impact of coagulation parameters on the outcomes of patients with severe community-acquired pneumonia requiring intensive care unit admission. Journal of Critical Care 2011 26 5 496 501 2-s2.0-80053452164 10.1016/j.jcrc.2011.02.001
68. Perren A., Cerutti B., Lepori M., Senn V., Capelli B., Duchini F., Domenighetti G., Influence of steroids on Procalcitonin and C-reactive protein in patients with COPD and community-acquired pneumonia. Infection 2008 36 2 163 166 2-s2.0-42249096941 10.1007/s15010-007-7206-5
69. Ridker P. M., Silvertown J. D., Inflammation, C-reactive protein, and atherothrombosis. Journal of Periodontology 2008 79 8 1544 1551 2-s2.0-49449116055 10.1902/jop.2008.080249
70. Vincent J. L., de Mendonça A., Cantraine F., Moreno R., Takala J., Suter P. M., Sprung C. L., Colardyn F., Blecher S., Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Critical Care Medicine 1998 26 11 1793 1800 2-s2.0-0031735051 (Pubitemid 28527688)
71. Hochreiter M., Köhler T., Schweiger A. M., Keck F. S., Bein B., von Spiegel T., Schroeder S., Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Critical Care 2009 13 3 R83 2-s2.0-67650917117 10.1186/cc7903
72. Schmit X., Vincent J. L., The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis. Infection 2008 36 3 213 219 2-s2.0-45849104786 10.1007/s15010-007-7077-9
73. Vincent J. L., Gustot T., Sepsis and cirrhosis: many similarities. Acta Gastro-Enterologica Belgica 2010 73 4 472 478 2-s2.0-79952134883